2-112388101-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001164463.1(RGPD8):c.4844G>A(p.Ser1615Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000025 ( 0 hom., cov: 15)
Exomes 𝑓: 0.000060 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
RGPD8
NM_001164463.1 missense
NM_001164463.1 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: 1.99
Genes affected
RGPD8 (HGNC:9849): (RANBP2 like and GRIP domain containing 8) Predicted to contribute to GTPase activator activity. Predicted to be involved in NLS-bearing protein import into nucleus. Predicted to be part of nuclear pore. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.054511935).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGPD8 | NM_001164463.1 | c.4844G>A | p.Ser1615Asn | missense_variant | 20/23 | ENST00000302558.8 | NP_001157935.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGPD8 | ENST00000302558.8 | c.4844G>A | p.Ser1615Asn | missense_variant | 20/23 | 1 | NM_001164463.1 | ENSP00000306637 | P1 | |
RGPD8 | ENST00000409750.5 | c.4424G>A | p.Ser1475Asn | missense_variant | 19/22 | 1 | ENSP00000386511 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 3AN: 119216Hom.: 0 Cov.: 15 FAILED QC
GnomAD3 genomes
AF:
AC:
3
AN:
119216
Hom.:
Cov.:
15
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000602 AC: 61AN: 1013504Hom.: 0 Cov.: 14 AF XY: 0.0000608 AC XY: 31AN XY: 509458
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
61
AN:
1013504
Hom.:
Cov.:
14
AF XY:
AC XY:
31
AN XY:
509458
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000252 AC: 3AN: 119216Hom.: 0 Cov.: 15 AF XY: 0.0000176 AC XY: 1AN XY: 56736
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
3
AN:
119216
Hom.:
Cov.:
15
AF XY:
AC XY:
1
AN XY:
56736
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 16, 2022 | The c.4844G>A (p.S1615N) alteration is located in exon 20 (coding exon 20) of the RGPD8 gene. This alteration results from a G to A substitution at nucleotide position 4844, causing the serine (S) at amino acid position 1615 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MutPred
Gain of relative solvent accessibility (P = 0.0082);.;
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at